世界の慢性難治性咳（CRC）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Refractory Cough (CRC) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5661 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、慢性難治性咳（CRC）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（言語療法、理学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・慢性難治性咳（CRC）治療の市場動向 ・企業の競争状況、市場シェア ・慢性難治性咳（CRC）治療の種類別市場規模と予測2016-2027（言語療法、理学療法） ・慢性難治性咳（CRC）治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・慢性難治性咳（CRC）治療の北米市場規模2016-2027（アメリカ、カナダ） ・慢性難治性咳（CRC）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性難治性咳（CRC）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性難治性咳（CRC）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性難治性咳（CRC）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Nerre Therapeutics、Bellus Health、Attenua、Respivant Sciences、Shionogi） ・結論

Chronic refractory cough (CRC) refers to cough that persists after treatment according to guidelines. Among the patients who went to the cough specialist clinic, 20% to 46% had chronic refractory cough, and the quality of life and health of these patients were greatly affected.

Market Analysis and Insights: Global Chronic Refractory Cough (CRC) Treatment Market
The global Chronic Refractory Cough (CRC) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Refractory Cough (CRC) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Refractory Cough (CRC) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Refractory Cough (CRC) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Refractory Cough (CRC) Treatment market.

Global Chronic Refractory Cough (CRC) Treatment Scope and Market Size
Chronic Refractory Cough (CRC) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Refractory Cough (CRC) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Speech Therapy
Physiotherapy

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Nerre Therapeutics
Bellus Health
Attenua
Respivant Sciences
Shionogi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Speech Therapy
1.2.3 Physiotherapy
1.3 Market by Application
1.3.1 Global Chronic Refractory Cough (CRC) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Refractory Cough (CRC) Treatment Market Perspective (2016-2027)
2.2 Chronic Refractory Cough (CRC) Treatment Growth Trends by Regions
2.2.1 Chronic Refractory Cough (CRC) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Refractory Cough (CRC) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Refractory Cough (CRC) Treatment Industry Dynamic
2.3.1 Chronic Refractory Cough (CRC) Treatment Market Trends
2.3.2 Chronic Refractory Cough (CRC) Treatment Market Drivers
2.3.3 Chronic Refractory Cough (CRC) Treatment Market Challenges
2.3.4 Chronic Refractory Cough (CRC) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Refractory Cough (CRC) Treatment Players by Revenue
3.1.1 Global Top Chronic Refractory Cough (CRC) Treatment Players by Revenue (2016-2021)
3.1.2 Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Refractory Cough (CRC) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Refractory Cough (CRC) Treatment Revenue
3.4 Global Chronic Refractory Cough (CRC) Treatment Market Concentration Ratio
3.4.1 Global Chronic Refractory Cough (CRC) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Refractory Cough (CRC) Treatment Revenue in 2020
3.5 Chronic Refractory Cough (CRC) Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Refractory Cough (CRC) Treatment Product Solution and Service
3.7 Date of Enter into Chronic Refractory Cough (CRC) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Refractory Cough (CRC) Treatment Breakdown Data by Type
4.1 Global Chronic Refractory Cough (CRC) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Type (2022-2027)

5 Chronic Refractory Cough (CRC) Treatment Breakdown Data by Application
5.1 Global Chronic Refractory Cough (CRC) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Refractory Cough (CRC) Treatment Market Size (2016-2027)
6.2 North America Chronic Refractory Cough (CRC) Treatment Market Size by Type
6.2.1 North America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021)
6.2.2 North America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027)
6.2.3 North America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2027)
6.3 North America Chronic Refractory Cough (CRC) Treatment Market Size by Application
6.3.1 North America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021)
6.3.2 North America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027)
6.3.3 North America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2027)
6.4 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country
6.4.1 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2016-2021)
6.4.2 North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size (2016-2027)
7.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type
7.2.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2027)
7.3 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application
7.3.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2027)
7.4 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country
7.4.1 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Refractory Cough (CRC) Treatment Market Size (2016-2027)
9.2 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Type
9.2.1 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2027)
9.3 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Application
9.3.1 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2027)
9.4 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Country
9.4.1 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Chronic Refractory Cough (CRC) Treatment Introduction
11.1.4 Merck Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Nerre Therapeutics
11.2.1 Nerre Therapeutics Company Details
11.2.2 Nerre Therapeutics Business Overview
11.2.3 Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Introduction
11.2.4 Nerre Therapeutics Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
11.2.5 Nerre Therapeutics Recent Development
11.3 Bellus Health
11.3.1 Bellus Health Company Details
11.3.2 Bellus Health Business Overview
11.3.3 Bellus Health Chronic Refractory Cough (CRC) Treatment Introduction
11.3.4 Bellus Health Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
11.3.5 Bellus Health Recent Development
11.4 Attenua
11.4.1 Attenua Company Details
11.4.2 Attenua Business Overview
11.4.3 Attenua Chronic Refractory Cough (CRC) Treatment Introduction
11.4.4 Attenua Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
11.4.5 Attenua Recent Development
11.5 Respivant Sciences
11.5.1 Respivant Sciences Company Details
11.5.2 Respivant Sciences Business Overview
11.5.3 Respivant Sciences Chronic Refractory Cough (CRC) Treatment Introduction
11.5.4 Respivant Sciences Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
11.5.5 Respivant Sciences Recent Development
11.6 Shionogi
11.6.1 Shionogi Company Details
11.6.2 Shionogi Business Overview
11.6.3 Shionogi Chronic Refractory Cough (CRC) Treatment Introduction
11.6.4 Shionogi Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
11.6.5 Shionogi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Speech Therapy
Table 3. Key Players of Physiotherapy
Table 4. Global Chronic Refractory Cough (CRC) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Chronic Refractory Cough (CRC) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Refractory Cough (CRC) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Chronic Refractory Cough (CRC) Treatment Market Share by Regions (2016-2021)
Table 8. Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Chronic Refractory Cough (CRC) Treatment Market Share by Regions (2022-2027)
Table 10. Chronic Refractory Cough (CRC) Treatment Market Trends
Table 11. Chronic Refractory Cough (CRC) Treatment Market Drivers
Table 12. Chronic Refractory Cough (CRC) Treatment Market Challenges
Table 13. Chronic Refractory Cough (CRC) Treatment Market Restraints
Table 14. Global Chronic Refractory Cough (CRC) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Chronic Refractory Cough (CRC) Treatment Market Share by Players (2016-2021)
Table 16. Global Top Chronic Refractory Cough (CRC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Refractory Cough (CRC) Treatment as of 2020)
Table 17. Ranking of Global Top Chronic Refractory Cough (CRC) Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Chronic Refractory Cough (CRC) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chronic Refractory Cough (CRC) Treatment Product Solution and Service
Table 21. Date of Enter into Chronic Refractory Cough (CRC) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Chronic Refractory Cough (CRC) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Chronic Refractory Cough (CRC) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Chronic Refractory Cough (CRC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Chronic Refractory Cough (CRC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Chronic Refractory Cough (CRC) Treatment Product
Table 64. Merck Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Nerre Therapeutics Company Details
Table 67. Nerre Therapeutics Business Overview
Table 68. Nerre Therapeutics Chronic Refractory Cough (CRC) Treatment Product
Table 69. Nerre Therapeutics Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021) & (US$ Million)
Table 70. Nerre Therapeutics Recent Development
Table 71. Bellus Health Company Details
Table 72. Bellus Health Business Overview
Table 73. Bellus Health Chronic Refractory Cough (CRC) Treatment Product
Table 74. Bellus Health Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021) & (US$ Million)
Table 75. Bellus Health Recent Development
Table 76. Attenua Company Details
Table 77. Attenua Business Overview
Table 78. Attenua Chronic Refractory Cough (CRC) Treatment Product
Table 79. Attenua Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021) & (US$ Million)
Table 80. Attenua Recent Development
Table 81. Respivant Sciences Company Details
Table 82. Respivant Sciences Business Overview
Table 83. Respivant Sciences Chronic Refractory Cough (CRC) Treatment Product
Table 84. Respivant Sciences Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021) & (US$ Million)
Table 85. Respivant Sciences Recent Development
Table 86. Shionogi Company Details
Table 87. Shionogi Business Overview
Table 88. Shionogi Chronic Refractory Cough (CRC) Treatment Product
Table 89. Shionogi Revenue in Chronic Refractory Cough (CRC) Treatment Business (2016-2021) & (US$ Million)
Table 90. Shionogi Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Refractory Cough (CRC) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Speech Therapy Features
Figure 3. Physiotherapy Features
Figure 4. Global Chronic Refractory Cough (CRC) Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Chronic Refractory Cough (CRC) Treatment Report Years Considered
Figure 9. Global Chronic Refractory Cough (CRC) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Chronic Refractory Cough (CRC) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Chronic Refractory Cough (CRC) Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Chronic Refractory Cough (CRC) Treatment Market Share by Regions (2022-2027)
Figure 13. Global Chronic Refractory Cough (CRC) Treatment Market Share by Players in 2020
Figure 14. Global Top Chronic Refractory Cough (CRC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Refractory Cough (CRC) Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Chronic Refractory Cough (CRC) Treatment Revenue in 2020
Figure 16. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Chronic Refractory Cough (CRC) Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Chronic Refractory Cough (CRC) Treatment Market Share by Type (2016-2027)
Figure 20. North America Chronic Refractory Cough (CRC) Treatment Market Share by Application (2016-2027)
Figure 21. North America Chronic Refractory Cough (CRC) Treatment Market Share by Country (2016-2027)
Figure 22. United States Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Refractory Cough (CRC) Treatment Market Share by Type (2016-2027)
Figure 26. Europe Chronic Refractory Cough (CRC) Treatment Market Share by Application (2016-2027)
Figure 27. Europe Chronic Refractory Cough (CRC) Treatment Market Share by Country (2016-2027)
Figure 28. Germany Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Chronic Refractory Cough (CRC) Treatment Market Share by Region (2016-2027)
Figure 38. China Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Refractory Cough (CRC) Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Chronic Refractory Cough (CRC) Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Chronic Refractory Cough (CRC) Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Chronic Refractory Cough (CRC) Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Chronic Refractory Cough (CRC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
Figure 58. Nerre Therapeutics Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
Figure 59. Bellus Health Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
Figure 60. Attenua Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
Figure 61. Respivant Sciences Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
Figure 62. Shionogi Revenue Growth Rate in Chronic Refractory Cough (CRC) Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---